CYP2C9 and Hypoglycemia: Consistent with the effect on hypoglycaemia, the interaction between CYP2C9 and POR genes also showed an association with the efficacy of SU treatment, assessed as a combined outcome of HbA1c reduction and prescribed SU daily dose.